Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Axon-to-Glia Interaction Regulates GabaA Receptor Expression in Oligodendrocytes.
Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis.
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Multiple sclerosis drugs: Sticker shock.
Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications.
Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV.
[One case of pediatric multiple sclerosis with convulsions as initial symptoms].
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
Alemtuzumab for the treatment of multiple sclerosis.
Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland.
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.
Neuronal gene transcription modulates demyelination and remyelination in a mouse model of multiple sclerosis.
LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis.
No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir Valley of India.
Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis.
[EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN ADULT RATS AFTER ADMINISTRATION OF INTERLEUKIN-1beta DURING DIFFERENT PERIODS OF EARLY LIFE].
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Mouse Hepatitis Virus infection remodels Connexin43 mediated gap junction intercellular communication both in vitro and in vivo.
KV1 channels identified in rodent myelinated axons, linked to Cx29 in innermost myelin: Support for electrically-active myelin in mammalian saltatory conduction.
Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
Pages
« first
‹ previous
…
706
707
708
709
710
711
712
713
714
…
next ›
last »